Betamethasone 17-benzoate

Betamethasone 17-benzoate is a representative steroid, which can be used in the treatment of recurrent aphothous ulcers (RAU) .

Product Specifications

CAS Number

[22298-29-9]

UNSPSC

12352005

Hazard Statement

H360-H373

Target

Glucocorticoid Receptor

Type

Reference compound

Related Pathways

Immunology/Inflammation; Vitamin D Related/Nuclear Receptor

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/MS1112.html

Solubility

10 mM in DMSO

Smiles

O=C(C1=CC=CC=C1)O[C@]2([C@@]3([C@@]([C@@]4([H])[C@@](F)([C@@]5(C(CC4)=CC(C=C5)=O)C)[C@@H](O)C3)([H])C[C@@H]2C)C)C(CO)=O

Molecular Formula

C29H33FO6

Molecular Weight

496.57

Precautions

P260-P280-P405-P501

References & Citations

[1]Barry BW, et al. Optimization of bioavailability of topical steroids: penetration enhancers under occlusion. J Invest Dermatol. 1984 Jan;82 (1) :49-52.|[2]ZFA (Stuttgart) . 1978 Jul 10;54 (19) :1031-2.|[3]Merchant HW, et al. Betamethasone-17-benzoate in the treatment of recurrent aphthous ulcers. Oral Surg Oral Med Oral Pathol. 1978 Jun;45 (6) :870-5.